Home » Topics » BioWorld Science

BioWorld Science
RSS

Boston Pharmaceuticals begins phase IIa study of BOS-589 in IBS-D

June 20, 2019

Recruitment ongoing in Immunocore's first-in-human study of IMC-C103C

June 20, 2019

Therapix reports phase IIa interim data on THX-110 in patients with obstructive sleep apnea

June 19, 2019

Ultomiris approved in Japan for PNH

June 19, 2019

CyTuVax reports results from phase II trial of HBAI-20 vaccine in hepatitis B nonresponders

June 19, 2019

Antitumor activity seen for acalabrutinib + pembrolizumab combination in relapsed/refractory DLBCL

June 19, 2019

Japan first to approve Breztri Aerosphere for COPD

June 19, 2019

Bevespi Aerosphere wins approval in Japan for COPD

June 19, 2019

Intuniv approved in Japan for adults with ADHD

June 19, 2019

FDA approves Keytruda for metastatic SCLC after platinum and other prior therapy

June 19, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...